Daniel Wu
- Indexed articles, last 90 days
- 5
- Latest publication
- Sep 24, 2026
- Outlet visibility, for Adn
- Top 50K sites
- Earliest in this view
- Jul 9, 2026
Latest articles
One blood test could screen you for 50 cancers. Hereâs why itâs controversial. (opens the original)
Read excerpt
A divided Food and Drug Administration panel narrowly backed a controversial blood-based cancer test Wednesday, a step forward for an emerging field of cancer screenings that could offer less invasive methods of detecting a range of cancers before symptoms appear. The test, Galleri, has been sold in the United States since 2021 but has not been approved by the FDA. It tests for fragments of DNA in a blood sample that could indicate the presence of cancer. Grail, the testâs manufacturer, says i
The screenings and other habits doctors recommend as early-onset cancers rise (opens the original)
Read excerpt
A microscopic, contrast-adjusted image of colon cancer cells. Some cancers can’t be screened for or are hard to detect, but there are many ways to help manage risk, experts say. Cancer death rates have fallen in recent years, and news this month about the advancement of groundbreaking research has stirred optimism for new treatments of melanoma, pancreatic cancer and beyond. But cancer rates are still rising among younger adults. And researchers have also identified disparities in diagnoses, wit
Cancer treatment could face landmark moment with promising vaccine (opens the original)
Read excerpt
An experimental drug that uses messenger RNA to deliver a vaccine customized to a patientâs tumors effectively prevented skin cancer recurrence in a large-scale clinical trial, according to new results announced by drugmakers Wednesday. Researchers have explored the use of mRNA drugs - the same technology behind the leading coronavirus vaccines that helped end the pandemic - to treat cancer for years, but this one is the first to clear a Phase 3 trial, according to Moderna and Merck. That open
FDA panel recommends loosening restrictions on peptides, despite scientistsâ concerns (opens the original)
Read excerpt
A divided Food and Drug Administration panel handed a significant victory to Health Secretary Robert F. Kennedy Jr.âs push to promote peptides, voting Thursday to recommend that certain pharmacies be allowed to produce four of the controversial wellness products despite FDA researchersâ calls for caution. The Pharmacy Compounding Advisory Committee voted to recommend loosening regulations on BPC-157, KPV, TB 500 and MOTS-c, which are among the seven peptides the committee is reviewing across
Cancer cases worldwide are expected to soar in the coming decades, a report finds. Hereâs why. (opens the original)
Read excerpt
Annual cancer cases are projected to rise considerably worldwide by 2050, according to a World Health Organization report on cancer published Wednesday. With its assessment, the United Nations body tempered optimism about improvements in cancer surveillance and treatment and warned that global health care inequities are driving further cases and deaths. Around 20.6 million people were diagnosed with cancer in 2024, according to the findings. That number could reach 35 million a year by 2050. The
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Adn, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.